EZH2 and carcinoma: Treatment of SAHA also caused significant decline in cell number in carcinoma cells when used synergistically with EZH2 siRNA; conversely, the expression of EZH2 and HDAC1/2 were decreased by SAHA treatment in TGBC2TKB cells [73].